MCMedicalCodingSoftware
Free trial
3E0L70M

3E0L70M — Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Antneo Moncln Ab in Pleural Cav, Via Opening

How 3E0L70M is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. LBody partThe specific site
  5. 7ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. MQualifierA further distinction where one applies

Codes near 3E0L70M

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0L3KZIntroduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach
  • 3E0L3NZIntroduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach
  • 3E0L3SFIntroduction of Other Gas into Pleural Cavity, Percutaneous Approach
  • 3E0L3TZIntroduction of Destructive Agent into Pleural Cavity, Percutaneous Approach
  • 3E0L45ZIntroduction of Adhesion Barrier into Pleural Cavity, Percutaneous Endoscopic Approach
  • 3E0L4GCIntroduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Endoscopic Approach
  • 3E0L704Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening
  • 3E0L705Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening
  • 3E0L70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening
  • 3E0L7SFIntroduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening
  • 3E0M05ZIntroduction of Adhesion Barrier into Peritoneal Cavity, Open Approach
  • 3E0M304Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach
  • 3E0M305Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach
  • 3E0M30MIntroduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
  • 3E0M30YIntroduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
  • 3E0M328Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach
  • 3E0M329Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach
ICD-10-PCSFY2026